MX346884B - Nuevos portadores recubiertos de agente activo de liberacion controlada. - Google Patents

Nuevos portadores recubiertos de agente activo de liberacion controlada.

Info

Publication number
MX346884B
MX346884B MX2014005466A MX2014005466A MX346884B MX 346884 B MX346884 B MX 346884B MX 2014005466 A MX2014005466 A MX 2014005466A MX 2014005466 A MX2014005466 A MX 2014005466A MX 346884 B MX346884 B MX 346884B
Authority
MX
Mexico
Prior art keywords
active agent
calcium carbonate
controlled release
natural
release active
Prior art date
Application number
MX2014005466A
Other languages
English (en)
Other versions
MX2014005466A (es
Inventor
A C Gane Patrick
Jean Ridgway Catherine
Schwarzentruber Patrick
Schoelkopf Joachim
Di Maiuta Nicola
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47143128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX346884(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP11188597.6A external-priority patent/EP2591772B1/en
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of MX2014005466A publication Critical patent/MX2014005466A/es
Publication of MX346884B publication Critical patent/MX346884B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

La presente invención se refiere a portadores para la liberación controlada de agentes activos, que comprenden un núcleo, contienen carbonato de calcio natural o sintético que ha reaccionado superficialmente y por lo menos un agente activo, en donde el por lo menos un agente activo está asociado con el carbonato de calcio natural o sintético que ha reaccionado superficialmente, y en donde el carbonato de calcio natural o sintético que ha reaccionado superficialmente es un producto de la reacción de carbonato de calcio natural o sintético con dióxido de carbono y uno o más ácidos, en donde el dióxido de carbono es formado in situ mediante el tratamiento con ácido y/o es suministrado desde una fuente externa, y un recubrimiento que encapsula el núcleo. Se refiere además a la preparación de portadores cargados, así como también a su uso en diferentes aplicaciones.
MX2014005466A 2011-11-10 2012-11-08 Nuevos portadores recubiertos de agente activo de liberacion controlada. MX346884B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11188597.6A EP2591772B1 (en) 2011-11-10 2011-11-10 New coated controlled release active agent carriers
US201161559253P 2011-11-14 2011-11-14
PCT/EP2012/072161 WO2013068478A1 (en) 2011-11-10 2012-11-08 New coated controlled release active agent carriers

Publications (2)

Publication Number Publication Date
MX2014005466A MX2014005466A (es) 2014-08-22
MX346884B true MX346884B (es) 2017-04-05

Family

ID=47143128

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014005466A MX346884B (es) 2011-11-10 2012-11-08 Nuevos portadores recubiertos de agente activo de liberacion controlada.

Country Status (24)

Country Link
US (1) US9579291B2 (es)
EP (1) EP2747752B1 (es)
KR (1) KR101612655B1 (es)
CN (1) CN103957893B (es)
AU (1) AU2012334082B2 (es)
BR (1) BR112014011310B1 (es)
CA (1) CA2851069C (es)
CL (1) CL2014001172A1 (es)
CO (1) CO6940430A2 (es)
DK (1) DK2747752T3 (es)
ES (1) ES2553091T3 (es)
IL (1) IL231959A0 (es)
IN (1) IN2014MN00843A (es)
MX (1) MX346884B (es)
MY (1) MY168425A (es)
PL (1) PL2747752T3 (es)
PT (1) PT2747752E (es)
RU (2) RU2665382C1 (es)
SG (1) SG11201401350WA (es)
SI (1) SI2747752T1 (es)
SM (1) SMT201600010B (es)
TW (1) TWI625129B (es)
WO (1) WO2013068478A1 (es)
ZA (1) ZA201403611B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2719376B1 (en) 2012-10-12 2015-03-04 Omya International AG Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
BR112015019387A2 (pt) * 2013-02-15 2017-07-18 Wellmark Int alimentação mineral - através de formulação
ES2690413T3 (es) * 2015-06-10 2018-11-20 Omya International Ag Uso de carbonato cálcico tratado mediante reacción superficial como agente antibloqueo
EP3176222A1 (en) * 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP3426706A1 (en) 2016-03-08 2019-01-16 Living Proof, Inc. Long lasting cosmetic compositions
EP3275947A1 (en) * 2016-07-25 2018-01-31 Omya International AG Surface-reacted calcium carbonate with functional cations
EP3400810A1 (en) 2017-05-11 2018-11-14 Omya International AG Surface-reacted calcium carbonate in food
CN107258776A (zh) * 2017-06-29 2017-10-20 山东大农药业有限公司 一种缓释农药颗粒剂及其制备方法
BR112020004127A2 (pt) 2017-09-13 2020-09-01 Living Proof, Inc. composições protetoras de cor
BR112020004215A2 (pt) 2017-09-13 2020-09-01 Living Proof, Inc. composições cosméticas de longa duração
EP3694491A1 (en) 2017-10-10 2020-08-19 Capsugel Belgium NV Gelling multiparticulates
EP3520798A1 (en) * 2018-01-31 2019-08-07 Omya International AG Use of functionalized calcium carbonate as active ingredient
US11896685B2 (en) 2018-10-31 2024-02-13 Amorepacific Corporation Core-shell network structure comprising biopolymer and composition comprising same
KR20200049662A (ko) * 2018-10-31 2020-05-08 (주)아모레퍼시픽 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물
US20220105047A1 (en) * 2019-01-16 2022-04-07 Research Cooperation Foundation Of Yeungnam University Microcapsule composition using alginate gel, and method for producing same
KR20210069344A (ko) 2019-12-03 2021-06-11 (주)아모레퍼시픽 바이오 폴리머를 포함하는 효능물질 전달체
CN111436426B (zh) * 2020-05-11 2022-04-08 北京首创股份有限公司 供水管道输水用二次加氯胶囊及其制备方法
AR123009A1 (es) 2020-07-20 2022-10-19 Omya Int Ag Agente estabilizante para composición probiótica

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2223896A1 (de) 1972-05-17 1973-11-29 Sanol Arznei Schwarz Gmbh Verfahren zum ueberziehen von feinteiligen arzneimitteln
US4657784A (en) 1986-03-10 1987-04-14 Ecolab Inc. Process for encapsulating particles with at least two coating layers having different melting points
DE59209706D1 (de) * 1992-12-01 1999-07-08 Spirig Ag S(+)-Ibuprofen enthaltende Arzneimittel
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
EP1891937A1 (en) 2006-08-25 2008-02-27 Novartis AG Galenic formulations of aliskiren
PT1974807E (pt) * 2007-03-21 2010-05-10 Omya Development Ag Processo para a remoção de compostos desreguladores endócrinos
EP2070991B1 (en) 2007-12-12 2010-09-08 Omya Development AG Process to make surface-reacted precipitated calcium carbonate
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
PL2421508T3 (pl) 2009-04-24 2017-06-30 Omya International Ag Materiał w postaci cząstek do kontrolowanego uwalniania składników czynnych
PT2264109E (pt) 2009-06-15 2012-05-09 Omya Development Ag Processo de preparação de carbonato de cálcio com superfície tratada por reacção e sua utilização
DK2264108T3 (da) 2009-06-15 2012-05-29 Omya Development Ag Fremgangsmåde til fremstilling af et calciumcarbonat, der har reageret på overfladen, under anvendelse af en svag syre

Also Published As

Publication number Publication date
IN2014MN00843A (es) 2015-07-03
KR20140091054A (ko) 2014-07-18
ES2553091T3 (es) 2015-12-04
BR112014011310B1 (pt) 2022-04-12
TWI625129B (zh) 2018-06-01
PT2747752E (pt) 2016-02-08
CN103957893A (zh) 2014-07-30
CA2851069C (en) 2016-05-31
SI2747752T1 (sl) 2015-12-31
CN103957893B (zh) 2017-08-15
BR112014011310A2 (pt) 2017-05-09
RU2018123688A3 (es) 2022-01-24
WO2013068478A1 (en) 2013-05-16
RU2018123688A (ru) 2019-03-07
AU2012334082A1 (en) 2014-04-24
EP2747752A1 (en) 2014-07-02
ZA201403611B (en) 2015-07-29
MX2014005466A (es) 2014-08-22
SG11201401350WA (en) 2014-05-29
US20140248340A1 (en) 2014-09-04
CL2014001172A1 (es) 2014-09-12
TW201328709A (zh) 2013-07-16
NZ623515A (en) 2016-09-30
US9579291B2 (en) 2017-02-28
RU2665382C1 (ru) 2018-08-29
DK2747752T3 (en) 2016-01-18
CA2851069A1 (en) 2013-05-16
SMT201600010B (it) 2016-02-25
IL231959A0 (en) 2014-05-28
KR101612655B1 (ko) 2016-04-14
PL2747752T3 (pl) 2016-04-29
AU2012334082B2 (en) 2015-10-29
MY168425A (en) 2018-11-09
CO6940430A2 (es) 2014-05-09
EP2747752B1 (en) 2015-10-07

Similar Documents

Publication Publication Date Title
MX2014005466A (es) Nuevos portadores recubiertos de agente activo de liberacion controlada.
TN2014000141A1 (en) New coated controlled release active agent carriers
UY32151A (es) Nuevo portador de agentes activos liberados de forma controlada
NZ705985A (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
MY183859A (en) Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
TN2014000133A1 (en) Environmentally friendly tanning composition
TN2011000370A1 (en) Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
MX340125B (es) 2-hidroxi-4-(metiltio) butironitrilo estable en almacenamiento.
EP2636451A4 (en) OXIDE CATALYST, PROCESS FOR PRODUCTION OF OXIDE CATALYST, PROCESS FOR PRODUCTION OF UNSATURATED ACID, AND PROCESS FOR PRODUCTION OF UNSATURATED NITRILE
SG191068A1 (en) New form of administration of enkephalinase inhibitor
EP2653221A4 (en) DEVICE AND METHOD FOR PRODUCING A CATALYST AND METHOD FOR PRODUCING UNSATURATED ACIDS OR UNSATURATED NITRILE
IN2014DN08496A (es)
MX2012002507A (es) Sales de percarbonato expandido, metodos de produccion y usos de la mismas.
PL2247573T3 (pl) Sole kwasu węglowego i siarkowego estrów 3-(2,2,2-trimetylohydrazynio)propionianów, oraz ich zastosowanie do wytwarzania dihydratu 3-(2,2,2-trimetylohydrazynio)propionianu
MY171509A (en) Toothpaste composition
SI2687506T1 (sl) Postopek za encimsko sintezo (7S)-1-(3,4-dimetoksibiciklo(4.2.0)okta-1,3,5-trien-7-il) N-metil metanamina ter uporaba za sintezo ivabradina in njegovih soli
IN2014MN00358A (es)
WO2014049020A3 (de) Vorrichtung und verfahren zur beschichtung von substraten
EP2589621A4 (en) PROCESS FOR DECOMPOSING POLYMYLIC ACID
UA61374U (ru) Способ стабилизаци полугидрата сульфата кальция
TH152833A (th) ตัวนำส่งสารออกฤทธิ์ที่ปลดปล่อยอย่างควบคุมชนิดเคลือบแบบใหม่
TN2013000243A1 (en) Substituted 1-benzylcycloalkylcarboxlic acids and use thereof
EP2528861A4 (en) ACTIVE OXYGEN SOURCE
WO2015042228A8 (en) A method for producing polycarbamate, a polycarbamate produced thereby and a coating containing the polycarbamate

Legal Events

Date Code Title Description
FG Grant or registration